SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Cameron McCoy, Jeffrey H. Lawson, Mark L. Shapiro, Management of Anticoagulation Agents in Trauma Patients, Clinics in Laboratory Medicine, 2014, 34, 3, 563

    CrossRef

  2. 2
    Samuel Lévy, Newer clinically available antithrombotics and their antidotes, Journal of Interventional Cardiac Electrophysiology, 2014,

    CrossRef

  3. You have free access to this content3
    A. Lai, N. Davidson, S. W. Galloway, J. Thachil, Perioperative management of patients on new oral anticoagulants, British Journal of Surgery, 2014, 101, 7
  4. 4
    Michael P. Miller, Toby C. Trujillo, Kristen E. Nordenholz, Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants, The American Journal of Emergency Medicine, 2014, 32, 4, 375

    CrossRef

  5. 5
    Nedaa Skeik, Kyle K. Rumery, Gabriel T. Rodriguez, The New Era of Anticoagulation, Annals of Vascular Surgery, 2014, 28, 2, 503

    CrossRef

  6. 6
    Genmin Lu, Francis R DeGuzman, Stanley J Hollenbach, Mark J Karbarz, Keith Abe, Gail Lee, Peng Luan, Athiwat Hutchaleelaha, Mayuko Inagaki, Pamela B Conley, David R Phillips, Uma Sinha, A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa, Nature Medicine, 2013, 19, 4, 446

    CrossRef

  7. 7
    D. M. Siegal, M. A. Crowther, Acute management of bleeding in patients on novel oral anticoagulants, European Heart Journal, 2013, 34, 7, 489

    CrossRef

  8. 8
    Gualtiero Palareti, Walter Ageno, Annamaria Ferrari, Alessandro Filippi, Davide Imberti, Vittorio Pengo, Andrea Rubboli, Danilo Toni, Clinical management of rivaroxaban-treated patients, Expert Opinion on Pharmacotherapy, 2013, 14, 5, 655

    CrossRef

  9. 9
    Jennifer E. Fugate, Alejandro A. Rabinstein, Robert D. McBane, Giuseppe Lanzino, Dabigatran: A Primer for Neurosurgeons, World Neurosurgery, 2013, 79, 1, 154

    CrossRef

  10. 10
    Anne-Céline Martin, Bernard Le Bonniec, Anne-Marie Fischer, Catherine Marchand-Leroux, Pascale Gaussem, Charles-Marc Samama, Anne Godier, Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis, International Journal of Cardiology, 2013, 168, 4, 4228

    CrossRef

  11. You have free access to this content11
    Mike Makris, Joost J. Veen, Campbell R. Tait, Andrew D. Mumford, Mike Laffan, Guideline on the management of bleeding in patients on antithrombotic agents, British Journal of Haematology, 2013, 160, 1
  12. 12
    Ruth S. Kuo, Wililiam D. Freeman, Rabih G. Tawk, Letter to the Editor: Anticoagulation, Journal of Neurosurgery, 2013, 118, 2, 483

    CrossRef

  13. 13
    Todd H. Baron, Patrick S. Kamath, Robert D. McBane, Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures, New England Journal of Medicine, 2013, 368, 22, 2113

    CrossRef

  14. 14
    Maria I. Aguilar, Ruth S. Kuo, William D. Freeman, New Anticoagulants (Dabigatran, Apixaban, Rivaroxaban) for Stroke Prevention in Atrial Fibrillation, Neurologic Clinics, 2013, 31, 3, 659

    CrossRef

  15. 15
    Tarek Y. El Ahmadieh, Salah G. Aoun, Marc R. Daou, Najib E. El Tecle, Rudy J. Rahme, Randall B. Graham, Joseph G. Adel, H. Hunt Batjer, Bernard R. Bendok, New-generation oral anticoagulants for the prevention of stroke: Implications for neurosurgery, Journal of Clinical Neuroscience, 2013, 20, 10, 1350

    CrossRef

  16. 16
    John N. Makaryus, Jonathan L. Halperin, Joe F. Lau, Oral anticoagulants in the management of venous thromboembolism, Nature Reviews Cardiology, 2013, 10, 7, 397

    CrossRef

  17. 17
    Jonathan L. Thigpen, Nita A. Limdi, Reversal of Oral Anticoagulation, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 11
  18. 18
    Scott Kaatz, Mark Crowther, Reversal of target-specific oral anticoagulants, Journal of Thrombosis and Thrombolysis, 2013, 36, 2, 195

    CrossRef

  19. 19
    Elizabeth Brem, Alex Koyfman, Mark Foran, Review of Recently Approved Alternatives to Anticoagulation with Warfarin for Emergency Clinicians, The Journal of Emergency Medicine, 2013, 45, 1, 143

    CrossRef

  20. 20
    Lawrence Tim Goodnough, A Reappraisal of Plasma, Prothrombin Complex Concentrates, and Recombinant Factor VIIa in Patient Blood Management, Critical Care Clinics, 2012, 28, 3, 413

    CrossRef

  21. You have free access to this content21
    Raf Brouns, Robbert-Jan Van Hooff, Ann De Smedt, Maarten Moens, Sylvie De Raedt, Maarten Uyttenboogaart, Gert-Jan Luijckx, Kristin Jochmans, Jacques De Keyser, Acute Stroke Management in Patients Taking Dabigatran, CNS Neuroscience & Therapeutics, 2012, 18, 8
  22. 22
    H. Sbai, B. Boukatta, A. El Bouazzaoui, M. El Youssfi, I. Mellouki, D. Allah Benajeh, H. El Bouhaddouti, M. Boubbou, S. Tizniti, A. Ibrahimi, K. Ait Taleb, N. Kanjaa, Complication rare de la coloscopie chez un patient sous anticoagulant : hémopéritoine par rupture d’un hématome sous-capsulaire de la rate, Acta Endoscopica, 2012, 42, 6, 304

    CrossRef

  23. 23
    E. S. Eerenberg, M. Levi, H. R. Büller, Contra: “Antidotes for novel anticoagulants?” -Do we really need them, Thrombosis and Haemostasis, 2012, 108, 4, 623

    CrossRef

  24. 24
    Eeric Truumees, Tracy Gaudu, Chad Dieterichs, Matthew Geck, John Stokes, Epidural Hematoma and Intraoperative Hemorrhage in a Spine Trauma Patient on Pradaxa (Dabigatran), Spine, 2012, 37, 14, E863

    CrossRef

  25. 25
    Juan Fernández-Armenta, Josep Brugada, Farmacología de dabigatrán y su manejo clínico, Revista Española de Cardiología Suplementos, 2012, 12, 18

    CrossRef

  26. You have free access to this content26
    Scott Kaatz, Peter A. Kouides, David A. Garcia, Alex C. Spyropolous, Mark Crowther, Jim D. Douketis, Anthony K. C. Chan, Andra James, Stephan Moll, Thomas L. Ortel, Elizabeth M. Van Cott, Jack Ansell, Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors, American Journal of Hematology, 2012, 87, S1
  27. 27
    Renato D. Lopes, Richard C. Becker, L. Kristin Newby, Eric D. Peterson, Elaine M. Hylek, Christopher B. Granger, Mark Crowther, Tracy Wang, Antonio C. Carvalho, Otavio Berwanger, Roberto R. Giraldez, Gilson Soares Feitosa, Jorge Pinto Ribeiro, Eduardo Darze, Renato A. K. Kalil, Marianna Andrande, Fabio Villas Boas, Jadelson Andrade, Ana Thereza Rocha, Robert A. Harrington, Antonio C. Lopes, David A. Garcia, Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil, Journal of Thrombosis and Thrombolysis, 2012, 34, 1, 143

    CrossRef

  28. 28
    Cecilia Becattini, Maria Cristina Vedovati, Giancarlo Agnelli, Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: A review of the literature, Thrombosis Research, 2012, 129, 3, 392

    CrossRef

  29. 29
    Charles Haviland Moore, Jonathan Snashall, Keith Boniface, James Scott, Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation, The American Journal of Emergency Medicine, 2012, 30, 9, 2082.e1

    CrossRef

  30. 30
    Satoshi Ogawa, Yukihiro Koretsune, Masahiro Yasaka, Yoshifusa Aizawa, Hirotsugu Atarashi, Hiroshi Inoue, Shiro Kamakura, Koichiro Kumagai, Hideo Mitamura, Ken Okumura, Kaoru Sugi, Takeshi Yamashita, Antithrombotic Therapy in Atrial Fibrillation, Circulation Journal, 2011, 75, 7, 1539

    CrossRef

  31. 31
    Michael Ganetsky, Kavita M. Babu, Steven D. Salhanick, Robert S. Brown, Edward W. Boyer, Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant, Journal of Medical Toxicology, 2011, 7, 4, 281

    CrossRef

  32. 32
    Roman M. Sniecinski, Marcie J. Hursting, Michael J. Paidas, Jerrold H. Levy, Etiology and Assessment of Hypercoagulability with Lessons from Heparin-Induced Thrombocytopenia, Anesthesia & Analgesia, 2011, 112, 1, 46

    CrossRef

  33. 33
    Renato D. Lopes, Richard C. Becker, John H. Alexander, Paul W. Armstrong, Robert M. Califf, Mark Y. Chan, Mark Crowther, Christopher B. Granger, Robert A. Harrington, Elaine M. Hylek, Stefan K. James, E. Marc Jolicoeur, Kenneth W. Mahaffey, L. Kristin Newby, Eric D. Peterson, Karen S. Pieper, Frans Werf, Lars Wallentin, Harvey D. White, Antonio C. Carvalho, Roberto R. Giraldez, Helio P. Guimaraes, Helena B. Nader, Renato A. K. Kalil, Joyce M. A. Bizzachi, Antonio C. Lopes, David A. Garcia, Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil, Journal of Thrombosis and Thrombolysis, 2011, 32, 2, 242

    CrossRef

  34. You have free access to this content34
    J. VAN ES, E. S. EERENBERG, P. W. KAMPHUISEN, H. R. BÜLLER, How to prevent, treat, and overcome current clinical challenges of VTE, Journal of Thrombosis and Haemostasis, 2011, 9,
  35. 35
    Elise S. Eerenberg, Josien van Es, Meertien K. Sijpkens, Harry R. Büller, Pieter W. Kamphuisen, New anticoagulants: Moving on from scientific results to clinical implementation, Annals of Medicine, 2011, 43, 8, 606

    CrossRef

  36. 36
    Alessandro Squizzato, Elena Rancan, Francesco Dentali, Pharmacotherapy of deep-venous thrombosis: current status and future perspective, Clinical Investigation, 2011, 1, 7, 1039

    CrossRef

  37. 37
    V. Pengo, L. Crippa, A. Falanga, G. Finazzi, F. Marongiu, G. Palareti, D. Poli, S. Testa, E. Tiraferri, A. Tosetto, A. Tripodi, C. Manotti, Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation, Thrombosis and Haemostasis, 2011, 106, 5, 868

    CrossRef

  38. 38
    Selvakumar Velu, Gregory YH Lip, Recent Progress in Antithrombotic Therapy for Atrial Fibrillation, Journal of Atherosclerosis and Thrombosis, 2011, 18, 4, 257

    CrossRef

  39. 39
    Renato D. Lopes, David Garcia, Richard C. Becker, Christopher B. Granger, L. Kristin Newby, John H. Alexander, E. Marc Jolicoeur, Allison Handler, Karen S. Pieper, Antonio C. Carvalho, Helio P. Guimaraes, Dalton A. F. Chamone, Antonio C. Baruzzi, Fabio S. Machado, Ari Timerman, Antonio C. Lopes, Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil, Journal of Thrombosis and Thrombolysis, 2010, 29, 4, 395

    CrossRef

  40. 40
    Luke R.E. Bereznicki, Gregory M. Peterson, REVIEW: New Antithrombotics for Atrial Fibrillation, Cardiovascular Therapeutics, 2010, 28, 5
  41. 41
    B. Heindl, M. Spannagl, Neue orale Antikoagulanzien, Der Anaesthesist, 2009, 58, 12, 1252

    CrossRef

  42. 42
    Marcello Di Nisio, Harry R. Büller, Antithrombotic Therapy in Venous Thrombosis and Pulmonary Embolism,